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2015–2019, and finally 91 days–1 year postoperatively 1.1 
(0.7–1.8) for 2010–2014 and 1.6 (1.0–2.6) for 2015–2019. 
From 1 to 5 years postoperatively, the risk of revision due to 
infection was similar to 2005–2009 for both the subsequent 
time periods
Interpretation — The risk of revision due to deep infec-
tion after THA increased throughout the period 2005–2019, 
but appears to have levelled out after 2010. The increase was 
mainly due to an increased risk of early revisions, and may 
partly have been caused by a change of practice rather than a 
change in the incidence of infection.
“Postoperative infection is the saddest of all complications…” 
John Charnley postulated in 1982 (Waugh and Charnley 
1990). Despite advances in knowledge and awareness of pro-
phylactic perioperative routines, there are indications that the 
incidence of infections after total hip arthroplasty (THA) is 
still increasing (Dale et al. 2012, Parvizi et al. 2013, Lenguer-
rand et al. 2017, Parvizi et al. 2017, Brochin et al. 2018, Kurtz 
et al. 2018). To disclose changes in the risk of infection we 
need a large number of primary THAs, registered in a uniform 
manner. The Norwegian Arthroplasty Register (NAR) found 
an increasing risk of deep infection after primary THA during 
the years 1987–2007. Over 10 years ago, Kurtz et al. (2007) 
projected a substantial demand for revisions due to infection in 
the coming decades. We have now assessed changes in the risk 
of surgical revision due to deep infection for THAs reported to 
the NAR during the years 2005 to 2019, as a follow-up of our 
previous study (Dale et al. 2009). In addition, we investigated 
factors that could be associated with revision, and the time 
span between primary and revision surgery. 
Background and purpose — Focus on prevention, sur-
veillance, and treatment of infection after total hip arthro-
plasty (THA) in the last decade has resulted in new knowl-
edge and guidelines. Previous publications have suggested 
an increased incidence of surgical revisions due to infection 
after THA. We assessed whether there have been changes in 
the risk of revision due to deep infection after primary THAs 
reported to the Norwegian Arthroplasty Register (NAR) over 
the period 2005–2019.
Patients and methods — Primary THAs reported to 
the NAR from January 1, 2005 to December 31, 2019 were 
included. Adjusted Cox regression analyses with the first 
revision due to deep infection after primary THA were per-
formed. We investigated changes in the risk of revision as a 
function of time of primary THA. Time was stratified into 
5-year periods. We studied the whole population of THAs, 
and the subgroups: all-cemented, all-uncemented, reverse 
hybrid (cemented cup), and hybrid THAs (cemented stem). 
In addition, we investigated factors that were associated with 
the risk of revision, and changes in the time span from pri-
mary THA to revision.
Results — Of the 108,854 primary THAs that met the 
inclusion criteria, 1,365 (1.3%) were revised due to deep 
infection. The risk of revision due to infection, at any time 
after primary surgery, increased through the period studied. 
Compared with THAs implanted in 2005–2009, the relative 
risk of revision due to infection was 1.4 (95% CI 1.2–1.7) for 
2010–2014, and 1.6 (1.1–1.9) for 2015–2019. We found an 
increased risk for all types of implant fixation. Compared to 
2005–2009, for all THAs, the risk of revision due to infec-
tion 0–30 days postoperatively was 2.2 (1.8–2.8) for 2010–
2014 and 2.3 (1.8–2.9) for 2015–2019, 31–90 days postop-
eratively 1.0 (0.7–1.6) for 2010–2014 and 1.6 (1.0–2.5) for 
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Patients and methods
Since its inception in 1987, the NAR has registered detailed 
data on primary THAs and THA revisions. The data gathered 
includes information on patient characteristics, indication 
for THA, and surgery-related factors such as approach, type 
of implant, method of fixation, and duration of surgery. The 
unique identification number of each inhabitant of Norway 
is used to link the primary THA to any subsequent revision 
(Havelin et al. 2000). The data is validated, with 97% com-
pleteness of reporting of primary THAs, 93% reporting of 
revisions, 100% coverage of Norwegian hospitals, and 100% 
reporting of deaths (Furnes et al. 2019).
Revision due to infection of the implant is defined as the 
removal or exchange of the whole or parts of the prosthesis, 
with deep infection reported as the reason for surgery. Isolated 
soft tissue debridement without the exchange of implant parts 
was not reported to the register until 2011, and was there-
fore not included. The surgeon completes the register form 
immediately after surgery, and the indication for the revision, 
infection or other, is based on perioperative assessment and 
evaluation. The diagnosis is not to be corrected in the NAR 
according to findings in peroperative bacterial samples. Due to 
this lack of validation, rate of revision due to infection will be 
only an approximation of the rate of true periprosthetic joint 
infection (PJI), as defined by Parvizi et al. (2018). 
The period of inclusion and observation in this study was 
January 1, 2005 to December 31, 2019. In this period, the 
NAR contained data on 116,779 primary THAs. 7,925 (7%) 
THAs were excluded due to missing information on covari-
ates. 108,854 primary THAs had complete information and 
were eligible for analyses. 
All THAs were followed until their first revision due to 
infection or revision for other causes after the primary opera-
tion, death, or emigration, or until December 31, 2019. Thus, 
follow-up was 0–15 years. 3 time periods according to the year 
of primary THA were compared: 2005–2009, 2010–2014, and 
2015–2019, with sub-analyses for the different THA fixa-
tion methods (all-cemented, all-uncemented, reverse hybrid 
[cemented cup], and hybrid [cemented stem]).
Statistics
Survival analyses were performed with Cox regression 
models, with year of primary THA as the main risk factor and 
date of revision due to deep infection as the endpoint. Revi-
sion hazard rate ratios (HRR) for the 2 later time periods rela-
tive to the 1st time period were calculated and presented as 
an expression of relative risk, with 95% confidence intervals 
(CI). We adjusted for the following: age (< 45, 45–54, 55–64, 
65–74, 75–84, ≥ 85 years), sex, ASA class, indication for the 
primary THA (osteoarthritis, inflammatory disease, acute 
hip fracture, complications after hip fracture, complications 
after childhood hip disease, avascular necrosis of the femoral 
head, other), surgical approach (anterior, anterolateral, lateral, 
posterolateral), duration of surgery (< 70, 70–99, 100–129, 
≥  130 minutes), and fixation (cemented, uncemented, reverse 
hybrid, or hybrid). Revisions due to infection in the case of 
monobloc THAs were not recorded if no implant parts were 
exchanged. We therefore adjusted for modularity of the pros-
thesis in the Cox analyses. In addition, we performed analyses 
where monobloc THAs (n = 3,936) were excluded. Monobloc 
implants were predominantly used early in the study period. 
More than 99.8% of the THA patients received perioperative 
antibiotic prophylaxis systemically, and for all cemented com-
ponents antibiotic-loaded bone cement was used. 
We used Cox regression analyses, with time period as the 
stratification factor, to construct cumulative revision curves 
(1 minus cumulative survival) at mean values of the covari-
ates, and to assess 5-year revision percentages. Analyses with 
follow-up restricted to 0–5 years for each period were per-
formed, to assess for the effect of differences in follow-up. 
In addition, analyses were performed without THAs with 
metal-on-metal articulations (n = 300), since metal debris 
reactions may mimic infection. Further, we performed sub-
analyses on THAs due to osteoarthritis only (n = 83,770), as 
a more homogenous subgroup. We also performed separate 
Cox analyses on revision due to aseptic loosening as endpoint 
for all THAs, to be able to compare these with our findings of 
revision due to infection. 
Revision HRR due to infection as a function of year of the 
primary THA was studied, to give a graphical display of the 
relationship based on a generalized additive model for survival 
data (Hastie and Tibshirani 1990). These curves are presented 
with 95% CIs. 
HRRs were calculated for the different potential risk fac-
tors for the whole 15-year period adjusted for year of primary 
THA, to adjust for time-dependent confounding. 
The analyses were performed in accordance with the guide-
lines for statistical analyses of arthroplasty register data (Rans-
tam et al. 2011a and b). The proportional hazard assumptions 
of the Cox survival analyses were not completely fulfilled 
between the 3 time periods when tested by smoothed Schoen-
feld residuals (see Figure 3). We therefore assessed the risk of 
revision due to infection 0–30 days, 31–90 days, 91 days–1 
year, and 1–5 years postoperatively. 
A study from the Swedish Knee Arthroplasty Register has 
found that potential overestimation of incidence of revision 
through the effect of competing risks (death and revision) 
is negligible, and that Cox analyses are better than compet-
ing risk analyses in estimating revision risks in arthroplasty 
register data (Ranstam and Robertsson 2017). Based on this 
we chose to include results only from Cox analyses. Bilateral 
THAs are dependent observations, but the influence of bilat-
erality on the outcome has been found to be negligible, also 
in the case of infection (Lie et al. 2004, Ranstam et al. 2011b, 
Dale et al. 2012). Hence, patients with bilateral THAs were 
included, and considered independent. 
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We calculated 95% CIs for survival rates and HRRs, and 
considered non-overlapping 95% CIs statistically significant. 
We used IBM SPSS 26.0 (IBM Corp, Armonk, NY, USA) and 
R statistical software packages for analyses (R Foundation for 
Statistical Computing, Vienna, Austria), and the study was 
performed in accordance with the STROBE and RECORD 
statements.
Ethics, data sharing plan, funding, and potential con-
flicts of interests
The registration of data and the study was performed confi-
dentially on patient consent and according to Norwegian and 
EU data protection rules. Data may be accessible upon appli-
cation to the NAR. The study was fully financed by the NAR, 
and no conflict of interest is declared. 
Results 
108,854 primary THAs in 91,621 patients met the inclusion 
criteria. 1,365 (1.3%) first revisions due to deep infection after 
primary THA were reported. Median follow-up was 5.4 (inter 
quartile range [IQR] 6.7) years, median age was 70 (IQR 14) 
years whereas mean ASA class for the THA patients was 2.0. 
Time trend of revision due to deep infection
The annual number of revisions due to infection is presented 
in Table 1, whereas the annual increase in risk of revision due 
to infection presented in Figure 1. We found that the risk of 
revision due infection was higher for the periods 2010–2015 
and 2015–2019 compared with 2005–2009. This finding was 
valid for all fixation methods. We found no difference between 
the 2 most recent periods, except for the cohort of uncemented 
THAs, in which there was an increased risk for revision due 
to infection in 2015–2019 (CI 1.4 [1.1–1.7]), compared with 
2010–2014, as well (Figure 2 and  Table 2, see Supplementary 
data). 
The increase in risk of revision due to infection was most 
pronounced in the first 30 postoperative days, but for 2015–
2019 we found an increased risk for the whole first postopera-
tive year (Figure 3 and  Table 3, see Supplementary data).
Excluding THAs with metal-on-metal articulation (n = 
300), THAs due to other causes than osteoarthritis, and mono-
bloc THAs did not alter our findings. Restricting follow-up for 
each period to 0–5 years also showed similar results. 
Factors associated with risk of revision due to infection 
The distribution of risk factors is presented in Table 4 (see Sup-
plementary data). Patient-related factors such as age, sex, and 
indication for primary THA was stable throughout the period 
studied. There was more comorbidity in patients undergoing 
primary THA, from mean ASA class 1.8 (SD 0.7) in 2005 
to 2.1 (SD 0.6) in 2019. The duration of surgery decreased 
slightly, the use of mono bloc stems was terminated, and there 
was a shift towards uncemented fixation. Further, the use of 
posterolateral, anterolateral, and anterior surgical approaches 
increased at the expense of the direct lateral approach, which 
used to be the most common in our country.
We assessed the impact of the different risk factors adjusted 
for in the Cox analyses, and the findings are presented in Table 5 
(see Supplementary data). Male sex, advanced age (> 75 years), 
and comorbidity (ASA class > 1) were patient-related factors 
associated with increased risk of revision due to infection. 
THA due to complications after hip fracture surgery and due to 
avascular necrosis of the femoral head was associated with an 
increased risk of revision due to infection, whereas THA due to 
Table 1. Absolute annual number of primary THAs and revisions due 
to infection for the period 2005–2019
Year of Number of THAs revised due to infection Number
primary 0–30 31–90 91 days 1–5  of primary
THA days days –1 year years Total (%)  THAs
2005 6 4 8 15   46 (0.9) 5,849
2006 10 6 6 23   55 (1.2) 5,816
2007 23 9 4 22   74 (1.2) 6,099
2008 30 10 10 17   78 (1.4) 6,327
2009 34 12 13 17   95 (1.5) 6,577
2010 53 11 10 18   98 (1.6) 6,722
2011 71 8 7 17  111 (1.3) 6,783
2012 54 10 13 16   98 (1.3) 7,272
2013 58 11 11 14   96 (1.3) 7,228
2014 47 14 11 11   84 (1.1) 7,333
2015 60 17 14 n.a.   n.a. 7,705
2016 65 18 17 n.a.   n.a. 8,247
2017 64 15 20 n.a.   n.a. 8,539
2018 72 16 12 n.a.   n.a. 9,053
2019 n.a. n.a. n.a. n.a.   n.a. 9,304









2005 2010 2015 2019
Year of primary THA
Figure 1. Relationship between year of primary surgery and risk of revi-
sion due to deep infection (with 95% confidence interval) for all THAs, 
adjusted for sex, age, ASA class, indication for primary THA, duration 
of surgery, surgical approach, and modularity of the THA. The broken 
line represents the HRR in 2005 (HRR = 1).
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THAs had lower risk. Compared with modular THAs, 
monobloc THAs apparently had half the risk of revi-
sion due to infection, as expected, since debridement 
of these were not reported to the NAR as a revision, as 
explained earlier.
Trends that may have contributed to the increased 
risk of revision for infection were a higher number of 
patients with substantial comorbidity, and more use of 
uncemented and hybrid THA (Tables 4 and 5, see Sup-
plementary data). Trends that may have contributed to 
less increase in risk of revision for infection were less 
use of the lateral surgical approach and shorter duration 
of surgery (Tables 4 and 5, see Supplementary data).
Time trend of revision due to aseptic loosening 
The risk of revision due to aseptic loosening, compared 
with 2005–2009, was decreasing, with 0.6 (CI 0.5–0.7) 
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Figure 2. Curves of adjusted revision-
percentage due to deep infection, for 
all THAs, for cemented THAs, unce-
mented THAs, reverse hybrid THAs, 
and hybrid THAs, for 3 periods of pri-
mary surgery, adjusted for sex, age, 
ASA class, indication for primary THA, 
duration of surgery, surgical approach, 





















Figure 3. The relationship between HRR of revision due to infection and time-
span postoperatively after primary THAs for the period 2010–2014 (red line) 
and 2015–2019 (green line) compared with 2005–2009 (blue lines). Smoothed 
Schoenfeld residuals adjusted for sex, age, ASA class, indication for primary 
THA, duration of surgery, surgical approach, and modularity of the THA (solid 
lines) with 95% confidence intervals (broken lines).
complications after childhood hip disease was associated with 
a lower risk. Long duration of surgery (> 100 minutes), and 
anterolateral and lateral surgical approaches were associated 
with a slightly higher risk of revision due to infection.
Uncemented and hybrid THAs had higher risk of revision 
due to infection than cemented THAs, whereas reverse hybrid 
Discussion
Our main finding was an increased risk for revision due to 
deep infection after primary THA for the 2 consecutive 5-year 
periods after 2005–2009. The most pronounced increase was 
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for THAs performed before 2010, whereafter the risk of revi-
sion due to infection seems to have levelled out. 
Our findings confirm the trend from earlier studies from 
the NAR and the Nordic Arthroplasty Register Associa-
tion (NARA) on the risk of revision due to infection (Dale 
et al. 2009, 2012). There are also other studies reporting an 
increased risk of PJI (Lenguerrand et al. 2017, Brochin et al. 
2018, Kurtz et al. 2018). The finding that the increase in PJI is 
flattening out after 2010 is in concordance with findings from 
New York State (Perfetti et al. 2017).
On the other hand, several infection surveillance regis-
tries report a trend of decreasing rates of surgical site infec-
tion (SSI) after THA, including both superficial and deep 
infections (Manniën et al. 2008, Choi et al. 2016, Sodhi et 
al. 2019). This was also the finding of the Norwegian Insti-
tute of Public Health’s SSI surveillance registry (Berg et 
al. 2019). The European Centre for Disease Prevention and 
Control (ECDC) reports a stable in-hospital incidence of SSI 
after total hip arthroplasty since 2011 (ECDC 2019), similar 
to what we found for that period. A review from 2015 reports 
increasing risk of SSI in several countries (Lamagni et al. 
2015). This variety in trends might be explained by the differ-
ences in definitions and duration of observation between SSIs 
reported in regional or national surveillance systems, and revi-
sion due to infection, as reported to the arthroplasty registers. 
SSI is observed at discharge from hospital or at post-discharge 
surveillance by a general physician (30 days, 90 days, or 1 
year postoperatively), in concordance with a specific set of 
diagnostic criteria and strict definition, and may be superfi-
cial or deep (ECDC 2017). In Norway, we have only 30 days’ 
surveillance of SSI after THA, but with good completeness 
since 2013 (Berg et al. 2019). In the NAR, however, the sur-
geon reports revision due to infection at any time after the 
primary THA. In our material, we found stable risk of revision 
due to infection in the first 30 days postoperatively for the 
period 2010–2019 (Table 3), in contrast to the slightly reduced 
incidence of SSIs from the Norwegian SSI surveillance pro-
gram in 2013–2018 (Berg et al. 2019). Even if we do not have 
absolute numbers for direct comparison, and the definitions of 
infection are different, this may reflect a trend towards more 
revisions being performed due to superficial SSIs and pro-
longed wound drainage, which would, in that case, result in an 
apparent increase in risk of infection in our material. 
Surgeons may report to the NAR debridement for prolonged 
wound drainage as revision due to infection. This revision 
strategy has evolved because prolonged wound drainage and 
superficial SSIs are strongly associated with PJI (Zhu et al. 
2015). Some of these cases will have negative cultures and 
will not fulfill criteria for a PJI. However, they remain regis-
tered as infections in the NAR. This may explain the discrep-
ancies between the 2 registers, at least to some degree.
For 2015–2019, we found an increased risk of revision due 
to infection in the first postoperative year. In contrast to our 
earlier findings, there was also an increased risk of revision 
later than 90 days postoperatively, which indicates a pro-
longed increase in risk of revision due to infection in recent 
years (Dale et al. 2012). 
The finding that the risk of revision increased more for the 
uncemented THAs compared with the other fixation methods 
may be explained by more frequent use of uncemented THAs 
in older patients with more comorbidity in recent years. The 
increased use of uncemented THA was most pronounced in 
2005–2009, and as uncemented THA was found to be a risk 
factor associated with revision due to infection, this may partly 
explain our finding of increased risk of revision due to infec-
tion during this period. All patients with cemented components 
in the present study had antibiotic-loaded bone cement. This 
has been found to be beneficial as prophylaxis against postop-
erative infection (Parvizi et al. 2008, Dale et al. 2012, Wang et 
al. 2013). Hybrid THAs, although few, had higher risk of revi-
sion due to infection compared with cemented THAs. This is in 
concordance with our previous and others’ findings (Pedersen 
et al. 2010b, Dale et al. 2012, Leong et al. 2020). 
Compared with our previous study, we now had the benefit 
of being able to adjust for ASA class. However, this did not 
change the finding of increased risk of revision due to infec-
tion. Even if risk factors for revision due to infection may 
differ from risk factors for PJI, one possible explanation for 
the increased risk of infection is that THA is now being per-
formed in frailer patients. We found an increase in mean ASA 
class for THA patients, and that ASA 2 and higher was associ-
ated with revision due to infection. The change in ASA class 
for THA patients was most pronounced between 2005–2009 
and 2010–2014. Some comorbidities, such as obesity and dia-
betes with hyperglycemia, are found to be potent risk factors 
for postoperative infection and have an increasing incidence 
in the population (Pedersen et al. 2010a, Jämsen et al. 2012, 
Lamagni et al. 2015, Liu et al. 2015). These specific risk fac-
tors are not reported to the NAR, and might, if in our material 
as in the general population the prevalence increases, and if 
not fully captured by ASA class, contribute to an increased 
risk of infection. 
In the present study primary THA for an acute hip fracture 
was more used in 2015–2019 than in 2005–2009. Acute hip 
fracture was not found to be a risk factor for revision due to 
infection. Displaced femoral neck fractures are recommended 
to be treated with hemiarthroplasty in old and frail patients with 
limited life expectancy (Gjertsen 2019). However, in patients 
expected to live longer, THA may the recommended treatment 
in certain cases. This selection of THA for healthier patients 
may explain why acute hip fracture was not found to be a risk 
factor for revision due to infection, as may have been expected.
There have been improvements in diagnostic procedures of 
PJI, and more standardized sampling, culturing, and analyzing 
techniques lead to fewer samples being false negative (Parvizi 
et al. 2016, Ting and Della Valle 2017). In addition, bacte-
ria like Staphylococcus epidermidis and Cutibacterium acnes 
have emerged as important agents of implant infection (Zeller 
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In summary, our finding of increased risk of revision is prob-
ably multifactorial. Partly it may reflect changes over time in 
reporting, revision threshold, diagnostics, surgeon awareness, 
surgical volume and skills, and the virulence and resistance of 
bacteria causing infection. An increase in the risk of revision 
due to infection in such cases will not reflect an increase in the 
incidence of PJI. 
On the other hand, if THA is performed on patients with 
more comorbidity, higher age, or implants or techniques asso-
ciated with a higher risk of infection are used, this would, as 
found in our study, contribute to an increased risk of infection 
after THA.
To conclude, the risk of revision due to infection after THA 
increased by approximately 50% through the period 2005–
2019. However, the increase in risk of revision due to infec-
tion appears to have levelled out after 2010. The increase was 
mainly caused by more revisions during the first postoperative 
year. Uncemented THAs were increasingly used during the 
study period, and also in patients with comorbidity, and we 
found a corresponding increase in risk of revision due to infec-
tion for uncemented THAs. In addition, THA patients had more 
comorbidity within all groups of fixation, and this may have 
contributed to the increased risk of revision due to infection. 
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detailed information on THA patients and primary and revi-
sion surgery, gathered uniformly over a long period. Our data 
are prospective and with acceptable completeness on possible 
risk factors for primary and revision THA (Furnes et al. 2019). 
We therefore have an excellent base for a trend study on a 
relatively rare complication like PJI. Since a large number of 
THAs from a nationwide population were included, external 
validity is expected to be good. 
Register studies do have, however, inherent limitations 
(Varnum et al. 2019). Even if we adjusted for several impor-
tant factors that could be associated with revision due to infec-
tion, there will be residual confounding. Such factors may be 
changes over time in reporting, revision threshold, diagnostics, 
surgeon awareness, selection of patients, and the virulence and 
resistance of bacteria causing infection. These factors may 
only partly be elucidated in a national arthroplasty register. 
Reported THA revision rates due to infection are not neces-
sarily the same as rates of PJI, although we have reason to 
believe that this is a close approximation, since guidelines 
recommend revision in the case of suspected infection, and 
reporting of revisions to the NAR is good. Improved report-
ing of revision due to infection may explain our findings to 
some degree. However, compared with validation studies from 
Sweden and Denmark, and considering the 93% reporting of 
revisions to the NAR, our reporting of revision due to infec-
tion resembles the “true” incidence of PJI reported from simi-
lar registers (Lindgren et al. 2014, Gundtoft et al. 2015, Furnes 
et al. 2019). Yet another limitation is that an erroneous diagno-
sis of infection is not corrected in the NAR, when results from 
peroperative bacterial sampling presents. This may lead to 
both under-reporting of low-grade infections and over-report-
ing in the case of negative bacterial cultures. Misreporting 
will only influence our findings if it changes during the period 
studied. Based on the findings of a slight decrease in risk of 
revision due to aseptic loosening and the fact that there may 
have been improvements in diagnostics and surgeons’ aware-
ness, there may have been a decrease in misreporting. 
Focus on the importance of thorough reporting has probably 
improved the reporting of revisions due to infection over the 
period studied. However, a time trend evaluation of this has 
not been performed.
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